Also, and most noteworthy, because FKBP51 may act on the genetic liability to abnormal mood and anxiety states, it may provide a much needed treatment tool for secondary prophylaxis of depression recurrence and relapse. The gene discussed is FKBP5; the disease is depressive symptom measurement.